Beijing Yishang Huicheng

Beijing Yishang Huicheng is a venture capital and investment firm based in Beijing, China, that focuses on funding early-stage biopharmaceutical and biotechnology startups. The organization primarily allocates its capital to clinical and preclinical companies developing innovative oncology treatments, with a specific emphasis on targeted therapies and immunotherapy drugs. Operating within the broader Asian life sciences sector, the firm provides financial backing to specialized drug developers seeking to advance their research pipelines. As an active participant in the medical venture space, Beijing Yishang Huicheng has supported notable portfolio companies such as FindCure Biosciences and KYinno. Specifically, the firm acted as a co-investor in KYinno's $15.7 million Series A funding round, which was officially completed in November 2021. The organization's exact founding year, total assets under management, and original founders currently remain undisclosed in public financial databases.